Hongchang International Co., Ltd

HCIL ·Healthcare, Medical Devices
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Operating Activities
Net Income $13.6K $-144.5K $-138.4K $-109.6K $-18.1K $-77.1K $-95.3K $-49.5K
Depreciation & Amortization $28.6K $22.2K $14.7K $22.7K — — — —
Depreciation — — $0 $0 — — — —
Amortization — — — $0 — — — —
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $-26.6K $-145.3K $1.9M $-947.5K $-116.4K $-61.5K $-18.2K $-29.7K
Investing Activities
Capital Expenditures $204.5K $-235.6K $-1.5M $42.1M — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-272.3K $250.5K $435.2K $-42.1M — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $568.3K $496.0K $-865.4K $40.7M $719.5K $1.1M $-28.1K $33.0K
Net Change in Cash $32.6K $-11.0K $868.9K $2.1K $1.9K $834 $-1.9K $-289
Free Cash Flow $-231.1K $90.2K $3.3M $-43.0M — — — —
← Newer Page 2 of 8 Older →